Single-step procedure for the extraction and purification of leukotrienes B₄, C₄ and D₄RICHMOND, R; TURNER, N. C; MALTBY, N et al.Journal of chromatography. 1987, Vol 417, Num 2, pp 241-251, issn 0021-9673Article

Ion-exchange high#performance liquid chromatographic determination of leukotrienes after precolumn derivatisation with o-phthaldialdehydeTSIKAS, D; BRUNNER, G.Fresenius' Zeitschrift für analytische Chemie. 1988, Vol 332, Num 4, pp 369-370, issn 0016-1152Article

Pharmacological characterization of leukotriene receptorsDAHLEN, S.-E.American journal of respiratory and critical care medicine. 2000, Vol 161, Num 2, pp S41-S45, issn 1073-449X, 2Conference Paper

Rate of Suicide in Patients Taking MontelukastJICK, Hershel; WILCOX HAGBERG, Katrina; EGGER, Pascal et al.Pharmacotherapy. 2009, Vol 29, Num 2, pp 165-166, issn 0277-0008, 2 p.Article

Successful drug treatment of immune reconstitution disease with the leukotriene receptor antagonist, montelukast : a clue to pathogenesis?LIPMAN, Marc C. I; CARDINE, Sally K.AIDS (London). 2007, Vol 21, Num 3, pp 383-384, issn 0269-9370, 2 p.Article

The national montelukast surveyBARNES, Neil; THOMAS, Mike; PRICE, David et al.Journal of allergy and clinical immunology. 2005, Vol 115, Num 1, pp 47-54, issn 0091-6749, 8 p.Article

Effect of montelukast on nuclear factor κB activation and proinflammatory moleculesMAEBA, Shinji; ICHIYAMA, Takashi; UENO, Yoshiko et al.Annals of allergy, asthma, & immunology. 2005, Vol 94, Num 6, pp 670-674, issn 1081-1206, 5 p.Article

Acquired thrombopathia related to montelukast therapyDUCHEMIN, Jerome; LION, Francois; ARNAUD, Bertrand et al.Thrombosis and haemostasis. 2004, Vol 91, Num 6, pp 1247-1248, issn 0340-6245, 2 p.Article

BLT1 and BLT2: the leukotriene B₄ receptorsTAGER, Andrew M; LUSTER, Andrew D.Prostaglandins, leukotrienes and essential fatty acids. 2003, Vol 69, Num 2-3, pp 123-134, issn 0952-3278, 12 p.Article

Leukotrienes C₄ and D₄ potentiate acid production by isolated rat parietal cellsSCHEPP, W; KATH, D; TATGE, C et al.Gastroenterology (New York, NY. 1943). 1989, Num 97, pp 1420-1429, issn 0016-5085Article

ICI 198615 is an antagonist of leukotriene C₄, leukotriene D₄ and leukotriene E₄ vasopressor responses in the conscious ratSMITH, E. F; SLIVJAK, M. J.Pharmacology. 1990, Vol 41, Num 2, pp 57-66, issn 0031-7012, 10 p.Article

Metabolism of leukotriene C₄, D₄ and E₄ in allergic inflammation in ratsOHUCHI, K; TARAHASHI, C; WATANABE, M et al.Journal of clinical & laboratory immunology. 1988, Vol 27, Num 4, pp 171-178, issn 0141-2760Article

Gastrointestinal damage induced by platelet-activating factor: role of leukotrienesWALLACE, J. L; MACNAUGHTON, W. K.European journal of pharmacology. 1988, Vol 151, Num 1, pp 43-50, issn 0014-2999Article

A Randomized Intervention of Montelukast for Post-Bronchiolitis: Effect on Eosinophil DegranulationKIM, Chang-Keun; CHOI, Jungi; HYO BIN KIM et al.The Journal of pediatrics. 2010, Vol 156, Num 5, pp 749-754, issn 0022-3476, 6 p.Article

Observational study of the effects of using montelukast vs fluticasone in patients matched at baselineALLEN-RAMEY, Felicia C; DUONG, Phong T; RIEDEL, Aylin A et al.Annals of allergy, asthma, & immunology. 2004, Vol 93, Num 4, pp 373-380, issn 1081-1206, 8 p.Article

Evaluation of CYP2C8 Inhibition In Vitro: Utility of Montelukast as a Selective CYP2C8 Probe SubstrateVANDENBRINK, Brooke M; FOTI, Robert S; ROCK, Dan A et al.Drug metabolism and disposition. 2011, Vol 39, Num 9, pp 1546-1554, issn 0090-9556, 9 p.Article

Reevaluation of the Microsomal Metabolism of Montelukast: Major Contribution by CYP2C8 at Clinically Relevant ConcentrationsFILPPULA, Anne M; LAITILA, Jouko; NEUVONEN, Pertti J et al.Drug metabolism and disposition. 2011, Vol 39, Num 5, pp 904-911, issn 0090-9556, 8 p.Article

Effect of the addition of montelukast to fluticasone propionate for the treatment of perennial allergic rhinitisESTEITIE, Rania; DETINEO, Marcy; NACLERIO, Robert M et al.Annals of allergy, asthma, & immunology. 2010, Vol 105, Num 2, pp 155-161, issn 1081-1206, 7 p.Article

Gemfibrozil Markedly Increases the Plasma Concentrations of Montelukast: A Previously Unrecognized Role for CYP2C8 in the Metabolism of MontelukastKARONEN, T; FILPPULA, A; LAITILA, J et al.Clinical pharmacology and therapeutics. 2010, Vol 88, Num 2, pp 223-230, issn 0009-9236, 8 p.Article

Montelukast during Primary Infection Prevents Airway Hyperresponsiveness and Inflammation after Reinfection with Respiratory Syncytial VirusJUNYAN HAN; YI JIA; TAKEDA, Katsuyuki et al.American journal of respiratory and critical care medicine. 2010, Vol 182, Num 4, pp 455-463, issn 1073-449X, 9 p.Article

EFFICACY AND SAFETY OF MONTELUKAST ADD-ON THERAPY IN ALLERGIC RHINITISMODGILL, V; BADYAL, D. K; VERGHESE, A et al.Methods and findings in experimental and clinical pharmacology. 2010, Vol 32, Num 9, pp 669-674, issn 0379-0355, 6 p.Article

MONTELUKAST TREATMENT IN CHILDREN WITH MODERATELY SEVERE ATOPIC DERMATITISEHLAYEL, M.-S; BENER, A; SABBAH, A et al.European annals of allergy and clinical immunology. 2007, Vol 39, Num 7, pp 232-236, issn 1764-1489, 5 p.Article

Amelioration of sepsis-induced hepatic and ileal injury in rats by the leukotriene receptor blocker montelukastSENER, Göksel; SEHIRLI, Özer; CETINEL, Sule et al.Prostaglandins, leukotrienes and essential fatty acids. 2005, Vol 73, Num 6, pp 453-462, issn 0952-3278, 10 p.Article

Montélukast contre la rhinite allergique chronique = Montelukast for chronic allergic rhinitisThe Medical letter on drugs and therapeutics (Edition française). 2005, Vol 27, Num 24, pp 132-133, issn 0253-8512, 2 p.Article

Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezingBACHARIER, Leonard B; PHILLIPS, Brenda R; GUILBERT, Theresa et al.Journal of allergy and clinical immunology. 2008, Vol 122, Num 6, pp 1127-1135, issn 0091-6749, 9 p.Article